GLPwatch
Trials (2083)
Page 26 of 35.
- A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass
- Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
- Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
- A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
- DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
- Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
- Human Bioequivalence Test of Liraglutide Injection
- Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity
- Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy
- A Study of CS060380 Tablets in Patients With MASH and Obesity
- Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3)
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
- The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes
- A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® and if the Ozempic®App Helps Them Stay on This Treatment
- Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
- Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes
- Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
- Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
- Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
- The Impact of Lixisenatide on Postprandial Glucose Tolerance in Pancreatectomised Subjects
- PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
- A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
- Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
- Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects
- Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
- Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
- Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide
- This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control
- Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or Obesity
- Exenatide for Myocardial Protection During Reperfusion Study
- Liraglutide in Newly Onset Type 1 Diabetes.
- Emulation of the SOUL Diabetes Trial in Healthcare Claims
- Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
- Epicardial Cardiac Fat-CT (EPIC-CT)
- Liraglutide in Type 1 Diabetes
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)
- Subcutaneous Semaglutide in Systemic Scleroderma
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice
- Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
- Trial for People With Established Type 2 Diabetes During Ramadan
- Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes
- Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
- Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
- Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
- Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects
- Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
- Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
- Comparison of Two Liraglutide Formulations in Healthy Volunteers
- Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
- Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
- Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying
- A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Digital Physical Activity Program
- Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
- Reversal to Normoglycemia by Treating Prediabetes